Amyotrophic lateral sclerosis, ALS, is a progressive neurodegenerative disease in which motor neurons are lost, leading to increasing muscle weakness and eventually affecting functions such as movement, speech, swallowing and breathing.
A simple family tree can make ALS look mostly “non-genetic” because many patients have no obvious close relative with the disease. Twin research shows why that conclusion is too quick.
Quick answer
How can “sporadic” ALS still have a strong genetic component?
Because genetic influence does not require one high-penetrance mutation running visibly through a family. Many variants can contribute small or moderate effects, variants can show incomplete penetrance, and disease can emerge through combinations of susceptibility and individual biological events.
Key takeaways
- A combined twin analysis identified 171 pairs in which at least one twin had ALS.
- Among identical twins there were five concordant and 44 discordant affected pairs; among fraternal twins there were no concordant and 122 discordant affected pairs.
- The study estimated heritability of sporadic ALS at 61%, with a wide 95% confidence interval of 38–78%.
- Most identical pairs were still discordant, so nearly identical inherited DNA did not make ALS inevitable.
- The study was published in 2010; its twin estimate remains informative, but its statements about how much ALS was explained by known genes are historically outdated because ALS genetics has advanced considerably since then.
171 twin pairs reveal a hidden genetic signal
Researchers combined population-based, clinic-based and earlier twin data to identify 171 twin pairs in which at least one member had ALS. Five monozygotic pairs were concordant for ALS and 44 were discordant. No dizygotic pairs were concordant and 122 were discordant.
Structural modelling estimated heritability for sporadic ALS at 61%, with a 95% confidence interval from 38% to 78%. The uncertainty interval is important: ALS is rare, and twin samples are necessarily much smaller than in studies of common traits.
Why “no family history” does not mean “not genetic”
Family history detects some forms of inheritance very well, especially when a high-risk variant is common in a family and penetrance is high. It is much less informative when risk is spread across many variants, when a variant is newly arisen, when relatives are small in number, or when not every carrier develops disease.
That is why a disease can be classified clinically as sporadic while still showing substantial genetic contribution at population level. Twin studies measure similarity patterns rather than relying only on visibly affected relatives.
Most identical pairs were still different
The most important counterweight to the 61% estimate is the pair count itself: 44 of the 49 monozygotic pairs with at least one affected twin were discordant in the analysed data.
This means a near-identical inherited genome was not sufficient to make disease appear in both twins during observation. In a classical twin model, the remaining component is often labelled “nonshared environment”, but that category is broader than everyday environment: it can also absorb individual biological events, measurement error and other factors that are not shared within the pair.
Gene discovery has moved forward since the twin paper
The 2010 article correctly argued that ALS has a meaningful genetic component, but its introductory count of known disease genes belongs to an earlier era. Since then, the genetic landscape of ALS has expanded substantially, including discoveries involving repeat expansions and additional disease genes.
For a modern reader, the durable result is therefore the twin estimate and the pattern of concordance — not the paper’s historical snapshot of how many cases researchers could explain molecularly at the time.
What remains to be discovered
ALS research has investigated many potential exposures and biological pathways, but the disease is rare and causal epidemiology is difficult. The twin study does not identify which individual-specific factors explain discordance.
That is precisely why discordant identical pairs remain useful: they can be used to generate and test hypotheses about molecular, epigenetic, metabolic and exposure differences while controlling much inherited background.
TwinPare perspective: “genetic” does not mean “single-gene” — and it does not mean inevitable
ALS is a particularly clear lesson in how misleading the phrase “genetic disease” can become. Genetic contribution can be substantial even without a simple family pattern, and substantial genetic contribution can coexist with many discordant identical twins.
The better question is not whether ALS is genetic. It is how inherited susceptibility interacts with the additional events required for disease to emerge.
Source notes
The source has been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [alchalabi-2010] An estimate of amyotrophic lateral sclerosis heritability using twin data Ammar Al-Chalabi et al.. Journal of Neurology, Neurosurgery & Psychiatry, 2010. Evidence type: Combined twin analysis and meta-analysis of 171 pairs in which at least one twin had ALS Limitation: Five monozygotic pairs were concordant and 44 discordant; no dizygotic pairs were concordant and 122 were discordant. Estimated sporadic ALS heritability was 61% (95% CI 38–78%). Gene discovery has advanced substantially since this 2010 paper, so its historical statements about the percentage explained by known genes should not be treated as current. PubMed PMC DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- The 61% heritability estimate has a wide confidence interval and comes from relatively small twin datasets because ALS is rare.
- Do not equate the twin-model “nonshared environment” component with one specific lifestyle exposure.
- The 2010 paper’s statements about the proportion explained by known ALS genes are historical and should not be presented as current 2026 genetics.
| ID | Claim | Source support | Caution |
|---|